'%2F%3E%3Cpath%20d%3D'M11%205H21M13.5%205V11.6A8.5%208.5%200%201%200%2018.5%2011.6V5'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.4'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Cpath%20d%3D'M10.6%2019.6L13.9%2021.8L17.6%2018.4L21.4%2020.4'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'2.6'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'17.6'%20cy%3D'18.4'%20r%3D'2.6'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
Nureca Limited
NURECA (NSE) · NURECA (BSE 543264) · ISIN INE0DSF01015 · Medical Equipment & Supplies · Est. 2016 · listed 2021 · website
ESM Stage 1 · NSE ESM Stage 1 · BSE
In Q2 FY27 (quarter to 30 September 2026, standalone), revenue was ₹58.6 cr and profit after tax ₹3.62 cr. Revenue was 54.9% higher than in Q2 FY26.
Open the full company file Every section, filings and your notes, in the app.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q2 FY27 standalone | ₹58.6 cr | ₹3.62 cr | 3.80 | 21 Oct 2026 |
| Q1 FY27 standalone | ₹40.4 cr | ₹2.43 cr | 2.55 | 21 Jul 2026 |
| Q4 FY26 standalone | ₹35.41 cr | −₹6.62 cr | −6.95 | 29 May 2026 |
| Q3 FY26 standalone | ₹39.64 cr | ₹3.23 cr | 3.39 | 17 Jan 2026 |
| Q2 FY26 standalone | ₹37.84 cr | ₹3.14 cr | 3.14 | 5 Jan 2026 |
| Q1 FY26 standalone | ₹34.32 cr | ₹0.55 cr | 0.55 | 15 Jul 2025 |
| Q4 FY25 standalone | ₹31.75 cr | ₹2.07 cr | 2.07 | 7 May 2025 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 30 Sep 2026 standalone | ₹183.21 cr | ₹1.71 cr | ₹220.34 cr |
| 31 Mar 2026 standalone | ₹177.16 cr | ₹0.67 cr | ₹193.54 cr |
| 30 Sep 2025 standalone | ₹196.17 cr | ₹0.88 cr | ₹213.19 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 70.68% | 0.22% | 0.24% | 29.32% |
Latest filings
- Nureca Limited has informed the Exchange regarding a press release dated October 21, 2026, titled "Nureca records highest quarterly revenue in last 20 quarters ; Q2 revenue rises 55% to Rs. 58.53 cror 21 October 2026 · NSE
- Nureca Limited has informed the Exchange regarding a press release dated October 21, 2026, titled "Nureca records highest quarterly revenue in last 20 quarters; Q2 revenue rises 55% to ₹58.53 cr 21 October 2026 · NSE
- Nureca Limited has informed the Exchange regarding a press release dated October 21, 2026, titled "Nureca records highest quarterly revenue in last 20 quarters; Q2 revenue rises 55% to ₹58.53 cr 21 October 2026 · NSE
- Nureca Limited has informed the Exchange regarding a press release dated October 21, 2026, titled "Nureca records highest quarterly revenue in last 20 quarters; Q2 revenue rises 55% to ₹58.53 cr 21 October 2026 · NSE
- Unaudited Financial results for the quarter ended June 30, 2026 21 July 2026 · BSE
Other companies in Medical Equipment & Supplies
- Laxmi Dental Limited
- QMS Medical Allied Services Limited
- Amkay Products Limited
- Hemant Surgical Industries Lim
- Vaidya Sane Ayurved Laboratories Limited
- Poly Medicure Limited
- Transpact Enterprises Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 21 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.